Open Access Maced J Med Sci. 2018 Jan 25; 6(1): 208–212.
Published online 2018 Jan 10. doi:10.3889/oamjms.2018.035
PMCID: PMC5816301
PMID: 29484025
Uwe Wollina,1,* André Koch,1 Dana Langner,1 Gesina Hansel,1 Birgit Heinig,2 Torello Lotti,3 and Georgi Tchernev4,5
Author information Article notes Copyright and License information PMC Disclaimer
Abstract
Acrocyanosis is an uncommon complaint belonging to the acro-syndromes. It typically presents with coolness and bluish discolourations of hands, feet, ears, nose, lips and nipple. The most frequently affected parts of the body are the hands. This review discusses physical factors, vascular disorders, infectious diseases, haematological disorders, solid tumours genetic disorders, drugs, eating disorders, and spinal disease presenting as or leading to acrocyanosis.
Keywords: Acrocyanosis, hands and feet, vascular disorders, Raynaud syndrome, Connective tissue diseases, Adverse drug reactions, Tumors
Introduction
Acrocyanosis is an uncommon complaint belonging to the acro-syndromes. It typically presents with coolness and bluish discolourations of hands, feet, ears, nose, lips and nipple. The most frequently affected parts of the body are the hands. Discoloration and coolness may be permanent or temporary and the result of a peripheral functional vascular disease and reduced tissue oxygenation. A great variety of conditions and disorders may be responsible for acrocyanosis [1]. Chronic idiopathic has been identified as a cutaneous sign of a “latent” cardiovascular risk [2].
Physical factors
Cold can induce vasospasm of digital arteries and arterioles resulting in acrocyanosis. The major differential diagnosis is perniones (chilblains) [3]. Sojourn in high altitude can cause some systemic diseases. From a dermatological point of view, acrocyanosis is a possible consequence due to the combination of lowered oxygen pressure, wind and cold temperatures [4].
Vascular disorders
Raynaud’s phenomenon is the most common underlying cause of acrocyanosis. It is characterised by paroxysmal reversible episodes of vasospasm, usually involving small peripheral vessels of the fingers or toes and resulting in a triple-colour change starting with pallor and followed by cyanosis and erythema. Attacks are typically triggered by cold or emotional stress [5].
Primary Raynaud’s syndrome must be differentiated from secondary Raynaud’s phenomenon seen in scleroderma, mixed connective tissue disease, dermatomyositis, systemic lupus erythematosus or anti-phospholipid syndrome [6][7].
Thoracic outlet syndrome is a compression of the neurovascular structures in the area superior to the first rib and posterior to the clavicle. Paget-Schröetter syndrome is an effort-induced thrombosis of the upper extremity. It is the leading vascular disorder in male athletes. The combination of both disorders can either lead to painful or painless acrocyanosis [8][9][10].
Primary vasculitis, such as giant cell arteritis, granulomatosis with polyangiitis, or essential cryoglobulinemic vasculitis, can lead to peripheral ischemic manifestations including acrocyanosis [11].
Infections
Chikungunya is a mosquito-borne viral infectious disease that has emerged as a global pathogen. Three to seven days after mosquito bite fever, rash, severe joint and muscle pains, and arthritis develop. It can spread vertically from mother to unborn child. Neonates infected intrauterine with chikungunya present with severe symptoms and infrequently death. Acrocyanosis progressing to ischemic digits is a typical symptom [12].
Acrocyanosis in a 74-year-old female with a herniated disk of the cervical spine. The differential diagnosis includes scleroderma, but sclerodactylia is absent
In rare cases of parvovirus B19 infection or lepromatous leprosy, acrocyanosis has been observed [13][14].
Persistent acrocyanosis with skin atrophy is a possible sign of late borreliosis – acrodermatitis chronic atrophicans (Herxheimer) [15].
Hematologic disorders
Cold agglutinin disease is a rare disorder with typical cutaneous signs such as livedo reticularis of the thighs, acrocyanosis and Raynaud’s phenomenon upon cold exposure [16].
In rare circ*mstances, chronic lymphocytic leukaemia can be associated with cold agglutinin disease [17]. Acrocyanosis has been observed in Hodgkin’s disease [18].
Essential thrombocythemia is a myeloproliferative neoplasm characterised by an increase in blood platelets. The most common cutaneous sign is itching, acrocyanosis, erythromelalgia, livedo reticularis, and Raynaud’s phenomenon are rare but possible manifestations [19].
POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy and Skin changes) syndrome is a rare systemic disease with the monoclonal proliferation of plasmacytes and slow progression. Cutaneous alterations are present in two-third of patients with diffuse cutaneous hyperpigmentation, and acrocyanosis [20].
Solid tumours
Acrocyanosis can be a rare symptom of extra-adrenal pheochromocytoma [21], intrahepatic carcinoid tumour [22], or endometrial adenocarcinoma [23]. This phenomenon has also been described under the terminus “paraneoplastic acral vascular syndrome” [24].
Genetic diseases
Aicardi-Goutières syndrome (AGS) caused by mutations in the SAMHD1 gene is characterised by early-onset encephalopathy and chilblains. Additional findings include acrocyanosis and Raynaud’s phenomenon [25].
Ethylmalonic encephalopathy is a rare metabolic disorder caused by mutations in the ETHE1 gene. Neurodevelopmental delay and regression, pyramidal and extrapyramidal involvement, episodes of acrocyanosis, recurrent petechiae and chronic diarrhoea are cardinal features of the disease. Characteristic metabolic findings include lactic acidemia, elevated plasma C4 and C5 acylcarnitines, C4 and C5 acyglycines, and substantial ethylmalonic aciduria [26].
Other possible underlying genetic diseases of acrocyanosis include fucosidosis, and oxaliosis [27][28][29].
Drug-induced
Ergot alkaloids used for the treatment of headaches and migraine can cause acrocyanosis and hand or leg ulcers [30]. Particular attention has to be paid in case of antiretroviral therapy since alkaloid action can be potentiated due to an inhibition of cytochrome P450 [31].
Liposomal amphotericin-B and amphotericin-B deoxycholate used for the treatment of systemic fungal infections have been reported to cause acrocyanosis that was reversible after discontinuation [32][33].
A bilateral foot acrocyanosis developed in a patient suffering from multiple sclerosis during interferon-β-treatment [34].
Tumescent liposuction for liposuction is known to cause acrocyanosis as a possible adverse effect. In severe cases, cyanosis, tachypnea, tachycardia, hypotension, confusion, or even death may be observed. Methemoglobinemia has been noted with all anaesthetics, such as lidocaine, prilocaine or ripivocaine, and patient safety demands laboratory monitoring of methemoglobin [35].
Acrocyanosis in a 71-year-old female after partial pulmonary resection due to malignant pheochromocytoma. The lesions developed with a delay of several months
Digital ischemia with acrocyanosis is a rare event during intravenous chemotherapy with gemcitabine, cisplatin or oxaliplatin [36]. Other drugs known to induce acrocyanosis are metoclopramide, imipramine, desipramin, and fluoxetine [27].
Eating disorders
Acrocyanosis is a possible cutaneous symptom of anorexia nervosa and bulimia nervosa due to persistent vasoconstriction associated with impairment of thermoregulation and reduced and delayed responsiveness to both vasodilator and vasoconstrictor agents [37][38].
Spinal disorders
Japanese authors described two male patients with cervical myelopathy, which exhibited peculiar vasomotor symptoms (“acro-erythro-cyanosis”). Continuous reddening, swelling and skin temperature increase were observed on both hands and feet or both hands. Cold stimulation resulted in paroxysmal cyanosis and a decrease in skin temperature [39].
Footnotes
Funding: This research did not receive any financial support
Competing Interests: The authors have declared that no competing interests exist
References
1. Kurklinsky AK, Miller VM, Rooke TW. Acrocyanosis:the Flying Dutchman. Vasc Med. 2011;16(4):288–301. https://doi.org/10.1177/1358863X11398519 PMid:21427140 PMCid:PMC3156491. [PMC free article] [PubMed] [Google Scholar]
2. Sampogna F, Camaioni DB, Giampetruzzi AR, Corona R, Ruzzi L, Silvestri L, Didona B. Chronic idiopathic acrocyanosis and methylenetetrahydrofolate reductase C677T (p.Ala222Val) and A1298C (p.Glu429Ala) polymorphisms. Eur J Dermatol. 2013;23(3):356–61. PMid:23816603. [PubMed] [Google Scholar]
3. Wollina U. Thermal and mechanical skin injuries. CME Dermatol. 2009;4(1):4–18. [Google Scholar]
4. Singh LC. High altitude dermatology. Indian J Dermatol. 2017;62(1):59–65. https://doi.org/10.4103/0019-5154.198050 PMid:28216727 PMCid:PMC5286755. [PMC free article] [PubMed] [Google Scholar]
5. Linnemann B, Erbe M. Raynaud's phenomenon - assessment and differential diagnoses. Vasa. 2015;44(3):166–77. https://doi.org/10.1024/0301-1526/a000426 PMid:26098320. [PubMed] [Google Scholar]
6. Wollina U, Verma SB. Acute digital gangrene in a newborn. Arch Dermatol. 2007;143(1):121–2. https://doi.org/10.1001/archderm.143.1.121 PMid:17224560. [PubMed] [Google Scholar]
7. Wollina U, Hein G. Lupus erythematosus:uncommon presentations. Clin Dermatol. 2005;23(5):470–9. https://doi.org/10.1016/j.clindermatol.2005.01.017 PMid:16179181. [PubMed] [Google Scholar]
8. Ahrazoglu M, Moinzadeh P, Hunzelmann N. [Differential diagnoses of Raynaud's phenomenon] Dtsch Med Wochenschr. 2014;139(20):1064–9. https://doi.org/10.1055/s-0034-1370036 PMid:24801303. [PubMed] [Google Scholar]
9. Kellar J, Trigger C. Thoracic outlet syndrome with secondary Paget Schröetter Syndrome:a rare case of effort-induced thrombosis of the upper extremity. West J Emerg Med. 2014;15(4):364–5. https://doi.org/10.5811/westjem.2014.4.21521 PMid:25035731 PMCid:PMC4100831. [PMC free article] [PubMed] [Google Scholar]
10. Norinsky AB, Espinosa J, Kianmajd M, DiLeonardo F. Painless acrocyanosis:Paget-Schroetter syndrome secondary to thoracic outlet obstruction from muscle hypertrophy. Am J Emerg Med. 2016;34(7):1323–e1.3. https://doi.org/10.1016/j.ajem.2015.11.050 PMid:26763826. [PubMed] [Google Scholar]
11. Gheita TA, Samad HM, Mahdy MA, Kamel AB. Pattern of primary vasculitis with peripheral ischemic manifestations:report of a case series and role of vascular surgery. Curr Rheumatol Rev. 2014;10(2):126–30. https://doi.org/10.2174/1573397110666150120103559 PMid:25599681. [PubMed] [Google Scholar]
12. Evans-Gilbert T. Chikungunya and neonatal immunity:Fatal vertically transmitted Chikungunya infection. Am J Trop Med Hyg. 2017;96(4):913–915. https://doi.org/10.4269/ajtmh.16-0491. [PMC free article] [PubMed] [Google Scholar]
13. Penouil MH, Estève E, Millotte B, Bressieux JM. [Parvovirus B19 atypical acrosyndrome] Ann Dermatol Venereol. 1997;124(3):254–6. PMid:9686060. [PubMed] [Google Scholar]
14. Cormier-Lebreton MN, Célérier P, Pasquiou C. [Autochthonal leprosy] Ann Dermatol Venereol. 1995;122(9):606–8. PMid:8745686. [PubMed] [Google Scholar]
15. Wollina U, Boldt S, Heinig B, Schönlebe J. Atypical acrodermatitis chronica atrophicans Herxheimer. Clin Res Dermatol Open Access. 2015;2(2):1–3. https://doi.org/10.15226/2378-1726/2/3/00122. [Google Scholar]
16. Gregory GP, Farrell A, Brown S. Cold agglutinin disease complicated by acrocyanosis and necrosis. Ann Hematol. 2017;96(3):509–510. https://doi.org/10.1007/s00277-016-2905-6 PMid:28050677. [PubMed] [Google Scholar]
17. Lesesve JF. Acrocyanosis revealing chronic lymphocytic leukemia. Clin Case Rep. 2016;4(4):404–5. https://doi.org/10.1002/ccr3.529 PMid:27099738 PMCid:PMC4831394. [PMC free article] [PubMed] [Google Scholar]
18. Solak Y, Aksoy S, Kilickap S, Celik I. Acrocyanosis as a presenting symptom of Hodgkin lymphoma. Am J Hematol. 2006;81(2):151–2. https://doi.org/10.1002/ajh.20479 PMid:16432859. [PubMed] [Google Scholar]
19. Cozzani E, Iurlo A, Merlo G, Cattaneo D, Burlando M, Pierri I, Gugliotta L, Parodi A. Essential thrombocythemia:The dermatologic point of view. Clin Lymphoma Myeloma Leuk. 2015;15(12):739–47. https://doi.org/10.1016/j.clml.2015.08.086 PMid:26432058. [PubMed] [Google Scholar]
20. Marinho FS, Pirmez R, Nogueira R, Cuzzi T, Sodré CT, Ramos-e-Silva M. Cutaneous manifestations in POEMS syndrome:Case report and review. Case Rep Dermatol. 2015;7(1):61–9. https://doi.org/10.1159/000381302 PMid:26034475 PMCid:PMC4448059. [PMC free article] [PubMed] [Google Scholar]
21. Kumar P, Ghosh S, Tanwar HS, Gupta AK. Acrocyanosis in a young adult:a rare presentation of extra-adrenal pheochromocytoma. BMJ Case Rep. 2014;2014 pii:bcr2013202845. [PMC free article] [PubMed] [Google Scholar]
22. Hari Kumar KV, Kumar A, Tomar D, Gupta AK. Acrocyanosis with intrahepatic carcinoid tumor. Indian Dermatol Online J. 2014;5(2):221–3. https://doi.org/10.4103/2229-5178.131139 PMid:24860770 PMCid:PMC4030363. [PMC free article] [PubMed] [Google Scholar]
23. Spinelli GP, Miele E, Lo Russo G, Rossi B, Tomao S. Acrocyanosis, digital ischemia and acronecrosis as first manifestations of endometrial adenocarcinoma:Case presentation and literature review. Int J Gynecol Clin Pract. 2016;2:113. https://doi.org/10.15344/2394-4986/2016/113. [Google Scholar]
24. Poszepczynska-GuignéE Viguier M, Chosidow O, Orcel B, Emmerich J, Dubertret L. Paraneoplastic acral vascular syndrome:epidemiologic features, clinical manifestations, and disease sequelae. J Am Acad Dermatol. 2002;47(1):47–52. https://doi.org/10.1067/mjd.2002.120474 PMid:12077580. [PubMed] [Google Scholar]
25. Yarbrough K, Danko C, Krol A, Zonana J, Leitenberger S. The importance of chilblains as a diagnostic clue for mild Aicardi-Goutières syndrome. Am J Med Genet A. 2016;170(12):3308–3312. https://doi.org/10.1002/ajmg.a.37944 PMid:27604406. [PubMed] [Google Scholar]
26. Yiş U, Polat İ, Karakaya P, Ayanoğlu M, Hiz AS. Importance of acrocyanosis in delayed walking. J Pediatr Neurosci. 2015;10(1):80–1. PMid:25878756; PMCid:PMC4395958. [PMC free article] [PubMed] [Google Scholar]
27. Das S, Maiti A. Acrocyanosis:an overview. Indian J Dermatol. 2013;58(6):417–20. https://doi.org/10.4103/0019-5154.119946 PMid:24249890 PMCid:PMC3827510. [PMC free article] [PubMed] [Google Scholar]
28. Jorquera-Barquero E, Súarez-Marrero MC, Fernández Girón F, Borrero Martín JJ. Oxalosis and livedo reticularis. Actas Dermosifiliogr. 2013;104(9):815–8. https://doi.org/10.1016/j.ad.2012.04.019 PMid:23103120. [PubMed] [Google Scholar]
29. Fleming C, Rennie A, Fallowfield M, McHenry PM. Cutaneous manifestations of fucosidosis. Br J Dermatol. 1997;136(4):594–7. https://doi.org/10.1111/j.1365-2133.1997.tb02149.x PMid:9155966. [PubMed] [Google Scholar]
30. Wollina U, Hansel G, Gruner M, Schönlebe J, Heinig B, Köstler E. Painful ANA-positive scleroderma-like disease with acral ulcerations:a case of chronic gangrenous ergotism. Int J Low Extrem Wounds. 2007;6(3):148–52. https://doi.org/10.1177/1534734607305308 PMid:17909173. [PubMed] [Google Scholar]
31. Cifuentes M D, Blanco L S, Ramírez FC. [Ergotism due to simultaneous use of ergot alkaloids and high activity antiretroviral therapy] Rev Med Chil. 2016;144(6):807–12. https://doi.org/10.4067/S0034-98872016000600017 PMid:27598502. [PubMed] [Google Scholar]
32. Zhang X, Jin J, Cai C, Zheng R, Wang Y, Xu Y. Amphotericin B liposome-induced acrocyanosis and elevated serum creatinine. Indian J Pharmacol. 2016;48(3):321–3. https://doi.org/10.4103/0253-7613.182889 PMid:27298506 PMCid:PMC4900009. [PMC free article] [PubMed] [Google Scholar]
33. Ozaras R, Yemisen M, Mete B, Mert A, Ozturk R, Tabak F. Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex. Mycoses. 2007;50(3):242. https://doi.org/10.1111/j.1439-0507.2007.01360.x PMid:17472626. [PubMed] [Google Scholar]
34. Masuda H, Mori M, Araki N, Kuwabara S. Bilateral foot acrocyanosis in an interferon-β-treated MS patient. Intern Med. 2016;55(3):319. https://doi.org/10.2169/internalmedicine.55.6251 PMid:26831034. [PubMed] [Google Scholar]
35. Yildirim B, Karagoz U, Acar E, Beydilli H, Nese Yeniceri E, Tanriverdi O, Alatas OD, Kasap Ş. A case report of prilocaine-induced methemoglobinemia after liposuction procedure. Case Rep Emerg Med. 2015;2015:282347. https://doi.org/10.1155/2015/282347. [PMC free article] [PubMed] [Google Scholar]
36. Karabacak K, Kadan M, Kaya E, Durgun B, Arslan G, Doganci S, Bolcal C, Demirkilic U. Oxaliplatin induced digital ischemia and necrosis. Case Rep Vasc Med. 2015;2015:248748. https://doi.org/10.1155/2015/248748. [PMC free article] [PubMed] [Google Scholar]
37. Strumia R. Skin signs in anorexia nervosa. Dermatoendocrinol. 2009;1(5):268–70. https://doi.org/10.4161/derm.1.5.10193 PMid:20808514 PMCid:PMC2836432. [PMC free article] [PubMed] [Google Scholar]
38. Mitchell JE, Crow S. Medical complications of anorexia nervosa and bulimia nervosa. Curr Opin Psychiatry. 2006;19(4):438–43. https://doi.org/10.1097/01.yco.0000228768.79097.3e PMid:16721178. [PubMed] [Google Scholar]
39. Takahashi N, Kita K, Nagumo K, Yamanaka I, Hirayama K. [ “Acro-erythro-cyanosis” --peculiar vasomotor symptoms due to cervical hernial myelopathy] Rinsho Shinkeigaku. 1990;30(2):151–6. PMid:2350926. [PubMed] [Google Scholar]
